NCT05521217 is a clinical trial of MyotonPRO in Muscle Tone Poor, sponsored by Istanbul Medipol University Hospital.

Who is sponsoring NCT05521217?

NCT05521217 is sponsored by Istanbul Medipol University Hospital.

What drugs are being tested in NCT05521217?

Interventions in NCT05521217: MyotonPRO.

What condition does NCT05521217 study?

NCT05521217 studies Muscle Tone Poor, Spinal Muscular Atrophy.

Is NCT05521217 still recruiting?

NCT05521217 is currently status unknown. Last updated 25 October 2022.

Last reviewed 2022-10-25 · How we verify

NCT05521217

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myotonometer Intra- and Inter Examiner Reliability on Spinal Muscular Atrophy

Status unknown Last updated 25 October 2022

What this trial tests

trial testing MyotonPRO in Muscle Tone Poor in 30 participants. Status unknown.

Timeline

26 August 2022

Primary endpoint
15 October 2022

15 October 2022

Quick facts

Lead sponsor	Istanbul Medipol University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	26 August 2022
Primary completion	15 October 2022
Estimated completion	15 October 2022
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

MyotonPRO

Conditions studied

Muscle Tone Poor — all drugs for Muscle Tone Poor →
Spinal Muscular Atrophy — all drugs for Spinal Muscular Atrophy →

Sponsor

Istanbul Medipol University Hospital

Who can join

Adults 1 Month to 4, any sex, with Muscle Tone Poor or Spinal Muscular Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of the study was to measure the intra-rater and inter-rater reliability of MyotonPRO in measuring postural muscle tone and mechanical properties in individuals with spinal muscular atrophy (SMA). The secondary aim is to question the existence of a relationship between the functional levels of individuals with SMA and their muscle tone and biomechanical properties. It is assumed that the outputs to be obtained from this research will form the norm data for moyotonometer evaluation in children with SMA.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Intersession Intra-Rater and Inter-Rater Reliability of Myotonometer for Upper and Lower Extremity Muscles in Children with Spinal Muscular Atrophy.
Kutlutürk Yıkılmaz S, Çevik Saldıran T, Öztürk Ö, Öktem S. · · 2024 · cited 1× · PMID 39451623 · DOI 10.3390/diagnostics14202300

Verify or expand the search:

Other trials of MyotonPRO

Trials testing the same drug.

NCT07086053 — Reliability of Myoton in Evaluating Skin Biomechanics in Breast Cancer-Related Lymphedema · NA · not yet recruiting
NCT05920837 — Relationship Between Upper Extremity' Viscoelastic Properties and Functionality in Subacute Stroke · unknown
NCT03840434 — COmpartment Syndrome vaLidation Of Non Invasive Assessment of Tissue Pressure · NA · completed

Other Istanbul Medipol University Hospital trials

Trials by the same sponsor.

NCT07508371 — Menthol Massage for Post-Bypass Pain & Anxiety · NA · not yet recruiting
NCT07575477 — Comparison Of Early Mobilization And Electrical Stimulation On Functional Recovery After Lumbar Disc Herniation Surgery · NA · not yet recruiting
NCT07525115 — Effects of Proprioceptive Neuromuscular Facilitation-Based Lower Extremity Training on Balance, Gait, and Functional Ind · NA · not yet recruiting
NCT07467278 — Low-FODMAP Diet and Intestinal Permeability in Patients With Irritable Bowel Syndrome · NA · not yet recruiting
NCT07468864 — Validity of the Turkish Situational Vertigo Questionnaire · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05521217 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medipol University Hospital
Last refreshed: 25 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05521217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing